Financial News
CureVac N.V. - Ordinary Shares (NQ:CVAC)
5.600
+1.530
(+37.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 12, 2025
Add to My Watchlist
All News about CureVac N.V. - Ordinary Shares




Via Benzinga

Via Benzinga

Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
May 25, 2022
From CureVac
Via AccessWire
Exposures
COVID-19


CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
April 28, 2022
From CureVac
Via AccessWire
Exposures
COVID-19





From CureVac
Via AccessWire

CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
March 30, 2022
From CureVac
Via AccessWire
Exposures
COVID-19




From CureVac
Via AccessWire








From CureVac
Via AccessWire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.